DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Hiret S, Bertaut A. et al.
Bevacizumab or cetuximab plus chemotherapy after progression with bevacizumab plus chemotherapy in patients with wtKRAS metastatic colorectal cancer: A randomized phase II study (Prodige 18 –UNICANCER GI).
J Clin Oncol 2016
34. suppl; abstr 3514
We do not assume any responsibility for the contents of the web pages of other providers.